EPISODE · Jan 16, 2026 · 7 MIN
The lure of the NASDAQ for Biotechs
from WTR Small-Cap Spotlight · host Water Tower Research
Send us Fan MailIn this special Flashcast episode of the WTR Small-Cap podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.
NOW PLAYING
The lure of the NASDAQ for Biotechs
No transcript for this episode yet
Similar Episodes
Apr 22, 2025 ·32m
Feb 27, 2025 ·0m
Sep 20, 2024 ·57m
Aug 7, 2024 ·16m